No takeover or bolt-on.
More generics in the pipeline and bookbuild to flog Arrow interests:
http://www.smh.com.au/news/Business/Sigma-extends-Arrow-product-pipeline/2007/04/12/1175971245801.html
No takeover or bolt-on.More generics in the pipeline and...
Add to My Watchlist
What is My Watchlist?